ClinicalTrials.gg
RecruitingNCT06525753Updated Jun 24, 2026

Weaning is Winning? (WeWin Study)

An observational study in Intestinal Failure and Parenteral Nutrition, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by The Hospital for Sick Children · Observational

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
120
Ages
0 Years to 18 Years
Sex
All
01

Study summary

We propose a multicenter prospective study on pediatric patients with intestinal failure (IF) who weaned off parenteral nutrition (PN).

Read the detailed description

Children with IF depend on PN. This is associated with frequent and various complications such as metabolic bone disease, micronutrient deficiencies and abnormal body composition. Due to advancements in care, many patients with IF are able to wean off PN; they are so called PN graduates. It is currently not well known how often complications do occur after weaning off PN, and which patients are at highest risk of developing these complications.

02

Conditions studied

  • Intestinal Failure
  • Parenteral Nutrition

Browse trials for

Keywords

  • Quality of Life
  • Pediatric
03

In context

Intestinal Failure

64 studies on the registry are indexed under Intestinal Failure; 17 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 19 observational studies indexed under Intestinal Failure.

Browse Intestinal Failure studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 578 studies on the registry; 83 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Parenteral Nutrition graduates, i.e.: patients weaned off Parenteral Nutrition at time of inclusion for at least 1 year, with a history of intestinal failure, defined as dependence on supplemental PN support for a minimum of 60 days within a 74 consecutive day interval and followed by the Group for Improvement of Intestinal Function and Treatment (GIFT) team (SickKids) or IF team (Erasmus MC) as an outpatient.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parenteral Nutrition graduates for at least 1 year, with a history of intestinal failure.
  • Age \<18 years at time of inclusion.

Exclusion criteria

Exclusion criteria:

  • No consent provided.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • SickKids

    Patients recruited from the Hospital for Sick Children (SickKids), Toronto, Canada

    Other: Weaning off Parenteral Nutrition

  • Erasmus

    Patients recruited from the Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands

    Other: Weaning off Parenteral Nutrition

Interventions

  • OtherWeaning off Parenteral Nutrition

    pediatric intestinal failure patients who have been weaned off parenteral nutrition

06

What researchers measure

Primary outcomes

  1. Complications

    Assess the frequency of nutritional complications including poor growth, micronutrient deficiencies, poor bone health, abnormal body composition, and delayed pubertal development in PN graduates.

    Time frame: From 1 year after weaning off PN to 18 years of age

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — All participants will be assigned a unique study ID (identification) known only to the study investigators/coordinators. The unique study IDs will only be identifiable through an encrypted master-linking log stored on a secure hospital server and shared folder that is only accessible to designated study staff on each site.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06525753
Responsible party
Jessie Hulst (Staff Physician, The Hospital for Sick Children) — Principal investigator
First posted
Jul 29, 2024
Start date
Jun 1, 2024
Primary completion
Jun 1, 2029 (estimated)
Completion
Jun 1, 2034 (estimated)
Last update
Jun 24, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion